ClinicalTrials.gov
ClinicalTrials.gov Menu

Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01316185
Recruitment Status : Terminated (the enrollment was slow and never completed.)
First Posted : March 16, 2011
Last Update Posted : August 8, 2016
Sponsor:
Information provided by (Responsible Party):
Eiger BioPharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : April 2013